Latest News & Features
Refine Search
Asia-Pacific
Criminal gangs in Australia are branching away from traditional forms of counterfeiting and are targeting pharmaceuticals, an Australian customs official has revealed. 9 October 2014
Genetics
A US appeals court has heard oral arguments in a case between Myriad Genetics and a generics company it wants to prevent from marketing its own test for BRCA gene mutations that can lead to breast cancer. 8 October 2014
Biotechnology
A patent belonging to Pluristem Therapeutics covering a treatment for ischemia has been upheld by the European Patent Office following opposition proceedings, the company has announced. 8 October 2014
Americas
US life sciences analysis company Sequenom has agreed a multi-million dollar deal to buy patents related to prenatal testing from UK-based technology transfer company Isis Innovation. 7 October 2014
Big Pharma
Drug business Teva invalidated two patents held by Leo Pharma today and will seek to launch a generic version of one of the company’s skin condition treatments. 6 October 2014
Big Pharma
Pharmaceutical company CleveXel Pharma has agreed a deal with a technology transfer company to licence two patents related to the treatment of bone marrow cancer. 6 October 2014
Americas
Law firm Blank Rome has expanded its litigation department with the appointment of life science specialist and partner Gary Ruckelshaus. 3 October 2014
Americas
US-based specialty drugs company Supernus Pharmaceuticals has sued generics maker Actavis, accusing it of infringing three patents related to an antiepileptic drug. 3 October 2014
Americas
Biopharmaceutical company Opexa Therapeutics has expanded its IP portfolio to include nearly 100 validated patents worldwide, the company has said. 1 October 2014
Americas
The Bay Area of California has one
of the greatest concentrations of life
sciences companies in the world,
but its biotech community is being
threatened by the seemingly
unstoppable rise of large technology businesses. LSIPR spoke to Christopher Stewart, chair, and Robert Eyler,
vice chair, of the new North Bay
Life Science Alliance to find out
how it plans to strengthen the network in the area. 30 September 2014